April 27Apr 27 Johnson & Johnson is leveraging artificial intelligence to significantly speed up drug development. The company has halved the time needed to identify promising new drug candidates. AI is also streamlining manufacturing processes and drastically reducing the time for preparing regulatory documents. View the full article
Create an account or sign in to comment